Skip to main content
logo
Tokyo Electron Limited (TOELY)
OTCMKTS · Delayed Price · Currency is USD
73.35
-4.90 (-6.26%)
Aug 1, 2025, 3:58 PM EDT

CTI BioPharma Revenue

In the fiscal year ending March 31, 2025, Tokyo Electron had annual revenue of 2.43T JPY with 32.83% growth. Tokyo Electron had revenue of 655.40B in the quarter ending March 31, 2025, with 19.75% growth.

Revenue
2,431.57B JPY
Revenue Growth
+32.83%
P/S Ratio
4.27
Revenue / Employee
124.23M JPY
Employees
19,573
Market Cap
69.29B USD

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20252,431.57B601.04B32.83%
Mar 31, 20241,830.53B-378.50B-17.13%
Mar 31, 20232,209.03B205.22B10.24%
Mar 31, 20222,003.81B604.70B43.22%
Mar 31, 20211,399.10B271.82B24.11%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Jingbo Technology2.29M
IPE Universal17.33M
AI Unlimited Group101.00
Rand Worldwide86.70M
Applied Energetics2.50M
EACO Corporation401.98M
Motomova989.88K
Abaxx Technologies601.14K
Revenue Rankings

Tokyo Electron News

More News